Bent Raungaard

3.1k total citations · 1 hit paper
55 papers, 1.1k citations indexed

About

Bent Raungaard is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bent Raungaard has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 35 papers in Cardiology and Cardiovascular Medicine and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bent Raungaard's work include Coronary Interventions and Diagnostics (31 papers), Cardiac Imaging and Diagnostics (20 papers) and Acute Myocardial Infarction Research (15 papers). Bent Raungaard is often cited by papers focused on Coronary Interventions and Diagnostics (31 papers), Cardiac Imaging and Diagnostics (20 papers) and Acute Myocardial Infarction Research (15 papers). Bent Raungaard collaborates with scholars based in Denmark, United Kingdom and Germany. Bent Raungaard's co-authors include Svend Eggert Jensen, Jens Aarøe, Thomas Engstrøm, Frants Pedersen, Anton Boel Villadsen, Lars Køber, Henning Kelbæk, Lene Holmvang, Steffen Helqvist and Lene Kløvgaard and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Bent Raungaard

51 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

2015 586 citations Thomas Engstrøm, Henning Kelbæk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bent Raungaard Denmark	13	837	826	549	91	71	55	1.1k
Michele Roesle United States	17	748 0.9×	1.1k 1.3×	571 1.0×	259 2.8×	94 1.3×	58	1.4k
Luigi Di Serafino Italy	18	786 0.9×	830 1.0×	658 1.2×	116 1.3×	56 0.8×	68	1.1k
S. Galatius Denmark	10	838 1.0×	550 0.7×	566 1.0×	97 1.1×	44 0.6×	18	1.1k
Yukio Nishida Japan	10	549 0.7×	492 0.6×	371 0.7×	99 1.1×	51 0.7×	16	784
Róisín Colleran Germany	15	458 0.5×	559 0.7×	297 0.5×	193 2.1×	44 0.6×	60	857
Sam J. Lehman Australia	13	563 0.7×	667 0.8×	499 0.9×	107 1.2×	42 0.6×	32	1.3k
Tairo Kurita Japan	19	601 0.7×	437 0.5×	596 1.1×	189 2.1×	27 0.4×	77	1.1k
Satoshi Daikoku Japan	15	644 0.8×	640 0.8×	509 0.9×	212 2.3×	36 0.5×	39	1.1k
Moritz Biener Germany	17	863 1.0×	267 0.3×	441 0.8×	36 0.4×	54 0.8×	55	1.0k
Alexander R. van Rosendael Netherlands	17	542 0.6×	323 0.4×	381 0.7×	95 1.0×	24 0.3×	57	811

Countries citing papers authored by Bent Raungaard

Since Specialization

Citations

This map shows the geographic impact of Bent Raungaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Raungaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Raungaard more than expected).

Fields of papers citing papers by Bent Raungaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bent Raungaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Raungaard. The network helps show where Bent Raungaard may publish in the future.

Co-authorship network of co-authors of Bent Raungaard

This figure shows the co-authorship network connecting the top 25 collaborators of Bent Raungaard. A scholar is included among the top collaborators of Bent Raungaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bent Raungaard. Bent Raungaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marquard, Jan, Rasmus Paulin Beske, Henning Kelbæk, et al.. (2025). 10-Year Outcome of Complete or Infarct Artery-Only Revascularization in STEMI With Multivessel Disease. Journal of the American College of Cardiology. 86(2). 119–129.

Christiansen, Evald Høj, Bent Raungaard, Anders Junker, et al.. (2023). Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventions. 103(2). 276–285.

Jensen, Lisette Okkels, Michael Mæng, Johnny Kahlert, et al.. (2023). Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial. Circulation Cardiovascular Interventions. 16(1). e012332–e012332. 7 indexed citations

Nepper‐Christensen, Lars, Henning Kelbæk, Kiril Aleksov Ahtarovski, et al.. (2022). Angiographic outcome in patients treated with deferred stenting after ST-segment elevation myocardial infarction—results from DANAMI-3-DEFER. European Heart Journal Acute Cardiovascular Care. 11(10). 742–748. 6 indexed citations

Kelbæk, Henning, Lars Nepper‐Christensen, Kiril Aleksov Ahtarovski, et al.. (2022). Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention. EuroIntervention. 18(6). 482–491. 9 indexed citations

Christiansen, Evald Høj, Bent Raungaard, Anders Junker, et al.. (2021). TCT-278 Five-Year Outcomes After Revascularization With the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent or the Biodegradable Polymer Biolimus-Eluting Nobori Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT VII Trial. Journal of the American College of Cardiology. 78(19). B114–B114. 1 indexed citations

Gyldenkerne, Christine, Morten Madsen, Troels Thim, et al.. (2019). Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus. SHILAP Revista de lepidopterología.

Christiansen, Evald Høj, Bent Raungaard, Johnny Kahlert, et al.. (2019). Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 12(7). 624–633. 23 indexed citations

Gyldenkerne, Christine, Kevin Kris Warnakula Olesen, Morten Madsen, et al.. (2019). <p>Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus</p>. Clinical Epidemiology. Volume 11. 419–428. 13 indexed citations

10.

Olesen, Kevin Kris Warnakula, Christine Gyldenkerne, Morten Madsen, et al.. (2019). <p>Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]</p>. Clinical Epidemiology. Volume 11. 721–722. 1 indexed citations

11.

Ellert, Julia, Lisette Okkels Jensen, Michael Mæng, et al.. (2018). TCT-90 Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII trial.. Journal of the American College of Cardiology. 72(13). B39–B39. 1 indexed citations

12.

Jakobsen, Lars, Evald Høj Christiansen, Michael Mæng, et al.. (2018). Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trial. American Heart Journal. 202. 49–53. 12 indexed citations

13.

Villadsen, Anton Boel, et al.. (2017). Chronic total coronary occlusion: treatment results. Scandinavian Cardiovascular Journal. 51(4). 197–201. 6 indexed citations

14.

Jakobsen, Lars, Christian Juhl Terkelsen, Evald Høj Christiansen, et al.. (2017). Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention. The American Journal of Cardiology. 120(4). 550–555. 22 indexed citations

15.

Jensen, Lisette Okkels, Michael Mæng, Bent Raungaard, et al.. (2016). TCT-451 Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial. Journal of the American College of Cardiology. 68(18). B181–B182. 1 indexed citations

16.

Nielsen, Morten Hjuler, et al.. (2016). The Impact of Lipoprotein‐Associated Oxidative Stress on Cell‐Specific Microvesicle Release in Patients with Familial Hypercholesterolemia. Oxidative Medicine and Cellular Longevity. 2016(1). 2492858–2492858. 20 indexed citations

17.

Tu, Shengxian, Lars Romer Krusell, Michael Mæng, et al.. (2014). Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study. International Journal of Cardiology. 182. 272–278. 36 indexed citations

18.

Kelbæk, Henning, Thomas Engstrøm, Kiril Aleksov Ahtarovski, et al.. (2013). Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention. 8(10). 1126–1133. 27 indexed citations

19.

Raungaard, Bent, et al.. (2001). LDL‐receptor gene mutations and the hypocholesterolemic response to statin therapy. Clinical Genetics. 59(6). 397–405. 12 indexed citations

20.

Raungaard, Bent, et al.. (2000). Flow Cytometric Assessment of Effects of Fluvastatin on Low‐Density Lipoprotein Receptor Activity in Stimulated T‐Lymphocytes from Patients with Heterozygous Familial Hypercholesterolemia. The Journal of Clinical Pharmacology. 40(4). 421–429. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact